The medical school will welcome Judy Lieberman, MD, PhD, in December as the latest speaker for Seminars in Investigative Medicine.
Dr. Lieberman will present “Immune Pore-forming Proteins: The New Bug Exterminators” from noon to 1:00 p.m. on Wednesday, December 5, in TBL 2 at the W.E. Upjohn M.D. Campus in downtown Kalamazoo.
A free lunch will be available from 11:45 a.m. to noon and Dr. Lieberman’s presentation will begin promptly at noon. The event is free and open to the public and CE and MEDU credit is available.
Dr. Lieberman is chair of Cellular and Molecular Medicine at Boston Children’s Hospital and a professor of Pediatrics at Harvard Medical School, and until recently was chair of the Executive Committee of Immunology at HMS.
The Lieberman laboratory studies cytotoxic T lymphocytes and their role in immune protection from infection and cancer. They study the molecular pathways used by killer lymphocytes to induce programmed cell death of both mammalian cells and microbes and the mechanism responsible for inflammatory death (pyroptosis) triggered by innate immune recognition of invasive pathogens and danger signals. Her laboratory has also been in the forefront of developing RNAi-based therapeutics and using RNAi for genome-wide screening. They were the first to show that siRNAs could be used to treat disease in vivo and to develop cell-targeted RNAs. They have developed strategies for cell-specific siRNAs that knockdown gene expression in vivo in T lymphocytes and cancer cells.
Currently they are studying aptamer-siRNAs for immune therapy of epithelial cancers. They also investigate the role of microRNAs in regulating cell differentiation and cancer.
Dr. Lieberman has received numerous awards for her research on AIDS vaccines, immunology and cancer. She is a member of the American Academy of Arts and Sciences.
Dr. Lieberman is part of an impressive slate of speakers for Seminars in Investigative Medicine for the 2018-2019 academic year.
In October, Bonnie B. Blomberg visited WMed for Seminars in Investigative Medicine and presented “Contributors to Vaccine Response: Aging, Obesity, and Inflammation.”
In January, the medical school will welcome Patrick C. Wilson, PhD, associate professor in the Department of Medicine-Section of Rheumatology at the University of Chicago.
In support of improving patient care, Western Michigan University Homer Stryker M.D. School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Western Michigan University Homer Stryker M.D. School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Number of credits subject to change.